Genetic ablation of Sfrp4 in mice does not affect serum phosphate homeostasis

Endocrinology

Volumn 152, Issue 5, 2011, Pages 2031-2036

  Christov, Marta ^a,b   Koren, Shany ^b   Yuan, Quan ^b   Baron, Roland ^b,c   Lanske, Beate ^b  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HARVARD SCHOOL OF DENTAL MEDICINE   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; KLOTHO PROTEIN; PHOSPHATE; SECRETED FRIZZLED RELATED PROTEIN 4;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; GENETIC ABLATION; GENETIC PROCEDURES; MOUSE; NONHUMAN; PHENOTYPE; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHOSPHATE URINE LEVEL; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; BLOTTING, WESTERN; CALCIUM; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HOMEOSTASIS; MALE; MICE; MICE, 129 STRAIN; MICE, INBRED C57BL; MICE, KNOCKOUT; PHENOTYPE; PHOSPHATES; PROTO-ONCOGENE PROTEINS; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIA; TIME FACTORS;

EID: 79955403724     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2010-1351     Document Type: Article

References (29)

1. Bergwitz C, Jüppner H 2010 Regulation of phosphate homeostasis by PTH, vitamin D, and FGF23. Annu Rev Med 61:91-104
2. Eddington H, Hoefield R, Sinha S, Chrysochou C, Lane B, Foley RN, Hegarty J, New J, O'Donoghue DJ, Middleton RJ, Kalra PA 2010 Serum phosphate and mortality in patients with chronic kidney disease. Clin J Am Soc Nephrol 5:2251-2257
3. Ganesh SK, Stack AG, Levin NW, Hulbert-Shearon T, Port FK 2001 Association of elevated serum PO (4), Ca x PO (4) product, and parathyroid hormone with cardiac mortality risk in chronic hemodialysis patients. J Am Soc Nephrol 12:2131-2138 (Pubitemid 32880350)
4. Shimada T, Hasegawa H, Yamazaki Y, Muto T, Hino R, Takeuchi Y, Fujita T, Nakahara K, Fukumoto S, Yamashita T 2004 FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis. J Bone Miner Res 19:429-435 (Pubitemid 38787398)
5. Urakawa I, Yamazaki Y, Shimada T, Iijima K, Hasegawa H, Okawa K, Fujita T, Fukumoto S, Yamashita T 2006 Klotho converts canonical FGF receptor into a specific receptor for FGF23. Nature 444:770-774 (Pubitemid 44949607)
6. Sitara D, Razzaque MS, Hesse M, Yoganathan S, Taguchi T, Erben RG, Jüppner H, Lanske B 2004 Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice. Matrix Biol 23:421-432 (Pubitemid 39576657)
7. Medici D, Razzaque MS, Deluca S, Rector TL, Hou B, Kang K, Goetz R, Mohammadi M, Kuro-O M, Olsen BR, Lanske B 2008 FGF-23-Klotho signaling stimulates proliferation and prevents vitamin D-induced apoptosis. J Cell Biol 182:459-465
8. De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC 2002 Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 17:1102-1110 (Pubitemid 34535149)
9. Berndt T, Craig TA, Bowe AE, Vassiliadis J, Reczek D, Finnegan R, Jan de Beur SM, Schiavi SC, Kumar R 2003 Secreted frizzled-related protein4 is a potent tumor-derived phosphaturic agent. J Clin Invest 112:785-794 (Pubitemid 38057719)
10. Berndt TJ, Bielesz B, Craig TA, Tebben PJ, Bacic D, Wagner CA, O'Brien S, Schiavi S, Biber J, Murer H, Kumar R 2006 Secreted frizzled-related protein-4 reduces sodium-phosphate co-transporter abundance and activity in proximal tubule cells. Pflugers Arch 451:579-587 (Pubitemid 41794027)
11. Cho HY, Choi HJ, Sun HJ, Yang JY, An JH, Cho SW, Kim SW, Kim SY, Kim JE, Shin CS 2010 Transgenic mice overexpressing secreted frizzled-related proteins (sFRP) 4 under the controlofserum amyloid P promoter exhibit low bone mass but did not result in disturbed phosphate homeostasis. Bone 47:263-271
12. Yam JW, Chan KW, Ngan ES, Hsiao WL 2005 Genomic structure, alternative splicing and tissue expression of rFrp/sFRP-4, the rat frizzled related protein gene. Gene 357:55-62 (Pubitemid 41267315)
13. Shimada T, Kakitani M, Yamazaki Y, Hasegawa H, Takeuchi Y, Fujita T, Fukumoto S, Tomizuka K, Yamashita T 2004 Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism. J Clin Invest 113:561-568 (Pubitemid 38542505)
14. Razzaque MS, Sitara D, Taguchi T, St. Arnaud R, Lanske B 2006 Premature aging-like phenotype in fibroblast growth factor 23 null mice is a vitamin D-mediated process. FASEB J 20:720-722 (Pubitemid 46671193)
15. Sitara D, Razzaque MS, St. Arnaud R, Huang W, Taguchi T, Erben RG, Lanske B 2006 Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals. Am J Pathol 169:2161-2170 (Pubitemid 351181975)
16. Stubbs JR, Liu S, Tang W, Zhou J, Wang Y, Yao X, Quarles LD 2007 Role of hyperphosphatemia and 1,25-dihydroxyvitamin D in vascular calcification and mortality in fibroblastic growth factor 23 null mice. J Am Soc Nephrol 18:2116-2124 (Pubitemid 47041077)
17. Ohnishi M, Razzaque MS 2010 Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 24:3562-3571
18. Nakatani T, Sarraj B, Ohnishi M, Densmore MJ, Taguchi T, Goetz R, Mohammadi M, Lanske B, Razzaque MS 2009 In vivo genetic evidence for klotho-dependent, fibroblast growth factor 23 (Fgf23)-mediated regulation of systemic phosphate homeostasis. FASEB J 23:433-441
19. Farrow E, Summers L, Schiavi S, McCormick J, Ellison D, White K 2010 Altered Renal FGF23-Mediated Activity Involving MAPK and Wnt: Effects of the Hyp Mutation. J Endocrinol 207:67-75
20. Maruyama T, Mirando AJ, Deng CX, Hsu W 2010 The balance of WNT and FGF signaling influences mesenchymal stem cell fate during skeletal development. Sci Signal 3: ra40
21. Ding VM, Ling L, Natarajan S, Yap MG, Cool SM, Choo AB 2010 FGF-2 modulates Wnt signaling in undifferentiated hESC and iPS cells through activated PI3-K/GSK3β signaling. J Cell Physiol 225:417-428
22. Surendran K, Schiavi S, Hruska KA 2005 Wnt-dependent β-catenin signaling is activated after unilateral ureteral obstruction, and recombinant secreted frizzled-related protein 4 alters the progression of renal fibrosis. J Am Soc Nephrol 16:2373-2384 (Pubitemid 41725055)
23. Romaker D, Puetz M, Teschner S, Donauer J, Geyer M, Gerke P, Rumberger B, Dworniczak B, Pennekamp P, Buchholz B, Neumann HP, Kumar R, Gloy J, Eckardt KU, Walz G 2009 Increased expression of secreted frizzled-related protein 4 in polycystic kidneys. J Am Soc Nephrol 20:48-56
24. Nakanishi R, Akiyama H, Kimura H, Otsuki B, Shimizu M, Tsuboyama T, Nakamura T 2008 Osteoblast-targeted expression of Sfrp4 in mice results in low bone mass. J Bone Miner Res 23:271-277 (Pubitemid 351160041)
25. Pande S, Ritter CS, Rothstein M, Wiesen K, Vassiliadis J, Kumar R, Schiavi SC, Slatapolsky E, Brown AJ 2006 FGF-23 and sFRP-4 in chronic kidney disease and post-renal transplantation. Nephron Physiol 104: p23-p32
26. Drake J, Shearwood AM, White J, Friis R, Zeps N, Charles A, Dharmarajan A 2009 Expression of secreted frizzled-related protein 4 (SFRP4) in primary serous ovarian tumours. Eur J Gynaecol Oncol 30:133-141
27. Huang D, Yu B, Deng Y, Sheng W, Peng Z, Qin W, Du X 2010 SFRP4 was overexpressed in colorectal carcinoma. J Cancer Res Clin Oncol 136:395-401
28. Karim RZ, Gerega SK, Yang YH, Horvath L, Spillane A, Carmalt H, Scolyer RA, Lee CS 2009 Proteins from the Wnt pathway are involved in the pathogenesis and progression of mammary phyllodes tumours. J Clin Pathol 62:1016-1020
29. Ohnishi M, Nakatani T, Lanske B, Razzaque MS 2009 In vivo genetic evidence for suppressing vascular and soft-tissue calcification through the reduction of serum phosphate levels, even in the presence of high serum calcium and 1,25-dihydroxyvitamin D levels. Circ Cardiovasc Genet 2:583-590